Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

Identifying these factors can help open the door to treatment and prevention options. Multiple sclerosis (MS) is a disease of the central nervous system. More than 2.8 million people worldwide ...

Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

The incidence of mental illness was higher among women with MS during both the prenatal period (incidence ratio [IR] 1.26, 95 ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving ...